Cited by 1,319Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismRegulation of Appetite and Obesity

Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects

Open access
Graham, Timothy E., Yang, Qin, Blüher, Matthias, Hammarstedt, Ann, Ciaraldi, Theodore P., Henry, Robert R., Wason, Christopher J., Oberbach, Andreas +3 more·2006·New England Journal of Medicine

Abstract

BACKGROUND: Insulin resistance has a causal role in type 2 diabetes. Serum levels of retinol-binding protein 4 (RBP4), a protein secreted by adipocytes, are increased in insulin-resistant states. Experiments in mice suggest that elevated RBP4 levels cause insulin resistance. We sought to determine whether serum RBP4 levels correlate with insulin resistance and change after an intervention that improves insulin sensitivity. We also determined whether elevated serum RBP4 levels are associated with reduced expression of glucose transporter 4 (GLUT4) in adipocytes, an early pathological feature of insulin resistance. METHODS: We measured serum RBP4, insulin resistance, and components of the metabolic syndrome in three groups of subjects. Measurements were repeated after exercise training in one group. GLUT4 protein was measured in isolated adipocytes. RESULTS: Serum RBP4 levels correlated with the magnitude of insulin resistance in subjects with obesity, impaired glucose tolerance, or type 2 diabetes and in nonobese, nondiabetic subjects with a strong family history of type 2 diabetes. Elevated serum RBP4 was associated with components of the metabolic syndrome, including increased body-mass index, waist-to-hip ratio, serum triglyceride levels, and systolic blood pressure and decreased high-density lipoprotein cholesterol levels. Exercise training was associated with a reduction in serum RBP4 levels only in subjects in whom insulin resistance improved. Adipocyte GLUT4 protein and serum RBP4 levels were inversely correlated. CONCLUSIONS: RBP4 is an adipocyte-secreted molecule that is elevated in the serum before the development of frank diabetes and appears to identify insulin resistance and associated cardiovascular risk factors in subjects with varied clinical presentations. These findings provide a rationale for antidiabetic therapies aimed at lowering serum RBP4 levels.

Integrity signals

Registry

Crossref · 10.1056/nejmoa054862

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In poorly nourished elderly subjects, oligofructose at 1.95-3.9 g per day for twelve weeks as part of a nutritional supplement had no effect on plasma TNF-α or sIL-6R concentrations.

    “In another study, in poorly nourished elderly subjects (age .70years), oligofructose (1•95-3•9 g/d for 12 weeks as part of a nutritional supplement) had no effect on plasma TNF-a or sIL-6R concentrations (838) .”
  • The secretion of proinflammatory cytokines and chemokines, as well as RBP4, contributes to the onset of the physiological alterations accompanying obesity.

    “The secretion of these proinflammatory cytokines and chemokines, as well as the secretion of other adipokines like retinol binding protein 4 (RBP4) 141, 142, is now well admitted to contribute to the onset of the physiological alterations accompanying obesity 12.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., & Kahn, B. B.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • VA San Diego Healthcare System (US)
  • Sahlgrenska University Hospital (SE)
  • University of California San Diego (US)
Venue
New England Journal of Medicine
Published
2006-06-15
Volume
354
Issue
24
Pages
2552-2563
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1979030077
Cited by
1,319
References
33
Citations by year
2026: 22 · 2025: 25 · 2024: 33 · 2023: 28 · 2022: 55 · 2021: 49 · 2020: 47 · 2019: 45 · 2018: 42 · 2017: 60 · 2016: 49 · 2015: 77 · 2014: 79 · 2013: 84 · 2012: 89
FWCI
85.43
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk058291-04)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK43051, R01DK-58291, K08DK069624, K08 DK-69624, R01DK043051)
  • National Center for Research Resources (M-01RR00827, M01RR000827)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
retinol-binding protein 4, insulin resistance, type 2 diabetes, obesity, metabolic syndrome, glucose transporter 4, adipocytes, exercise training, impaired glucose tolerance, cardiovascular risk factors, adipokines
MeSH terms
Adult, Blood Glucose, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Middle Aged, Obesity, Retinol-Binding Proteins, Thinness, Exercise, Adipocytes, Metabolic Syndrome, Glucose Metabolism Disorders, Glucose Transporter Type 4, Retinol-Binding Proteins, Plasma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review